EP2054498A1 - Procédé permettant d'isoler des protéines des cellules de production - Google Patents

Procédé permettant d'isoler des protéines des cellules de production

Info

Publication number
EP2054498A1
EP2054498A1 EP07788230A EP07788230A EP2054498A1 EP 2054498 A1 EP2054498 A1 EP 2054498A1 EP 07788230 A EP07788230 A EP 07788230A EP 07788230 A EP07788230 A EP 07788230A EP 2054498 A1 EP2054498 A1 EP 2054498A1
Authority
EP
European Patent Office
Prior art keywords
diaphragm
cell
pressure
cells
static mixer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07788230A
Other languages
German (de)
English (en)
Inventor
Thomas Danner
Tillmann Faust
Ulrike Richter
Thomas Subkowski
Marvin Karos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to EP07788230A priority Critical patent/EP2054498A1/fr
Publication of EP2054498A1 publication Critical patent/EP2054498A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material

Definitions

  • the invention relates to a method for cell disruption of biological cells and the subsequent isolation of proteins from production cells and to a device for this purpose.
  • a fermentatively produced product is present interacellularly, the cell must be disrupted after the end of the fermentation (enzyme or protein release). In this case, it is important to open the cell and release the inner cell components, especially the sought molecule, usually a protein, in the culture broth. It does not matter whether these proteins already exist in the desired native form or inactive as an inclusion body. In addition to the desired protein thereby also more soluble proteins are released.
  • the product can then be removed from the so-called cell debris after cell disruption, e.g. be separated by sedimentation in a centrifuge, by filtration or by fractional sedimentation and optionally further purified.
  • the physical forces used for cell disruption are mechanical forces that can be applied by impact, friction, stress, pressure, pressure, cavitation or sound. As a rule, several of these forces are generated in the machines and apparatus designed for this purpose.
  • the externally visible feature is the specific power input. The most effective use of the introduced energy with regard to the comminution effect is an important decision criterion for the method to be selected (Storhas W. Biochemical Development, Wiley-VCh Verlag GmbH & Co. KgaA Weinheim, 2003).
  • High-pressure homogenization is the most frequently used disintegration device in large-scale refurbishment practice.
  • the principle of the high-pressure homogenizer is based on a cavitation caused by the spontaneous pressure reduction, which leads to cell destruction with strong tension forces.
  • the decomposition of the cavitation vapor bubbles produces pressures of up to 10 5 bar, which are ultimately responsible for the destruction of the cell.
  • the suspension is usually supplied with a low admission pressure of the piston pump, which biases it to the homogenization pressure.
  • the valve In the homogenizer unit, the valve translates this pressure into speed, shear, normal and tensile forces. This creates a strong cavitating flow. These processes take depending on the pressure about 200 to 250 msec.
  • the main factors influencing the disintegration in the high-pressure homogenizer are theoretically the homogenization pressure difference, the number of passages, the design of the homogenizing valve, concentration of the feed concentration and temperature (Storhas, 2003).
  • the increase in temperature generally increases in proportion to the pressure difference used (about 2.2 0 C per 10 MPa, Storhas, 2003).
  • An increase in the product yield due to improved cell disruption at higher pressure differences is thus possibly counteracted by heat inactivation of the product.
  • An increase in the pressure difference to improve the cell digestion degree thus entails an increased cooling capacity.
  • the size of the cell debris resulting from mechanical cell disruption can directly influence the separation result in a plate separator (Wong et al., "Centrifugal processing of cell debris and inclusion bodies from recombinant E. coli, Bioseparation 6: 361-372, 1997). report a better separation performance of the unwanted cell debris of inclusion bodies when using a plate separator, if the size of the cell debris is reduced while the size of the inclusion body remains the same. A reduction in the cell debris size could be achieved in this case by increasing the homogenizer passages from 2 to 10. By producing smaller cell debris, which were preferably separated in the clear water of the separator, the purity of the inclusion body concentrate could be increased by 58%.
  • the processes described in the prior art require high amounts of energy, require repeating the digestion step several times, do not satisfy the quantitative yield of functional protein, use partially toxic substances and often introduce strong impurities with nucleic acids, which make further processing difficult. Often, the methods are also applicable for cost reasons only on a small scale, so that a technical production of proteins is not so profitable to perform.
  • the present invention therefore an object of the invention to provide a new method for the digestion of biological cells with a particularly good isolation of proteins from production cells succeed that avoids the above-mentioned disadvantages of the known methods.
  • the object was achieved by a method for the digestion of biological cells with which a particularly good isolation of proteins from production cells succeeds, by means of a homogenizer which a) consists of a diaphragm with at least one inlet nozzle and a diaphragm with at least one outlet nozzle, wherein in the space b) consists of a diaphragm with at least one inlet nozzle and a baffle plate, which optionally in the space between the diaphragm and the baffle plate is a static mixer and / or mechanical energy input takes place between the diaphragms a static mixer.
  • Another object of the invention is a method for isolating a protein from a production cell by means of a homogenizer, which a) consists of a diaphragm with at least one inlet nozzle and a diaphragm with at least one outlet nozzle, wherein in the space between the diaphragms a static mixer and optionally additionally mechanical energy input is effected or b) consists of a diaphragm with at least one inlet nozzle and a baffle plate, wherein in the space between the diaphragm and the baffle plate optionally a static mixer and / or mechanical energy input takes place.
  • the present invention also provides a device for the digestion of biological cells with which a particularly good isolation of proteins from production cells succeeds, the
  • a) consists of a diaphragm with at least one inlet nozzle and a diaphragm with at least one outlet nozzle, wherein there is a static mixer in the intermediate space between the diaphragms and if necessary additional mechanical energy input takes place
  • b) consists of a diaphragm with at least one inlet nozzle and a baffle plate, wherein in the space between the diaphragm and the baffle plate, if necessary, there is a static mixer and / or mechanical energy input takes place.
  • all types of biological cells can be disrupted and, in particular, proteins can be isolated particularly well from production cells following cell disruption.
  • the method according to the invention achieves a comparable degree of cell disruption at a significantly lower differential pressure (about a factor of 2) compared with the prior art. In other words, at the same differential pressure, a higher cell disruption level is achieved over the prior art.
  • the expense required for the subsequent killing of the biological cells by e.g. Conti-sterilization or chemical addition can be significantly reduced.
  • the properties of the cell fragments are influenced so that a subsequent separation of the cell fragments via a separator or nozzle separator is significantly facilitated.
  • the method is preferably used for cell disruption if subsequently non-enzymatic proteins have to be isolated, in particular if surface-active proteins have to be isolated. Especially succeeds in the subsequent isolation of proteins of microbial, plant origin, especially of proteins from the class of hydrophobins.
  • Hydrophobins are small proteins of about 100 AA, which are characteristic of filamentous fungi and do not occur in other organisms. Recently, hydrophobin-like proteins have been discovered in Streptomyces coelicolor, also known as "chapliners,” which also have high surface-active properties, and at water-air interfaces can chapline into amyloid-like fibrils (Classen et al., 2003) Genes Dev 1714-1726; Elliot et al., 2003, Genes Dev. 17, 1727-1740).
  • Hydrophobins are distributed in a water-insoluble form on the surface of various fungal structures, such as aerial hyphae, spores, fruiting bodies.
  • the genes for hydrophobins could be isolated from ascomycetes, deuteromycetes and basidiomycetes.
  • Some fungi contain more than one hydrophobin, eg Schizophyllum commune, Coprinus cinereus, Aspergillus nidulans.
  • different hydrophobins are involved in different stages of fungal development. The hydrophobins are probably responsible for different Microbiol., 36, 201-210 (Kershaw et al., 1998, Fungal Genet., Biol, 1998, 23, 18-33).
  • hydrophobins As a biological function for hydrophobins, in addition to reducing the surface tension of water to generate aerial hyphae, the hydrophobization of spores is also described (Wösten et al., 1999, Curr. Biol., 19, 1985-88, Bell et al., 1992 , Genes Dev., 6, 2382-2394). Hydrophobins also serve to line gas channels in lichen fructoids and as components in the plant surface recognition system by fungal pathogens (Lugones et al., 1999, Mycol Res., 103, 635-640, Hamer & Talbot 1998, Curr. Opinion Microbiol. , Vol. 1, 693-697).
  • the process according to the invention can also be used with great success for the isolation of fusion proteins.
  • fusion proteins These are proteins which have at least one polypeptide chain which does not occur in this form in nature and has been artificially composed of two parts.
  • the process according to the invention is suitable for the isolation of hydrophobins.
  • hydrophobins for the process according to the invention are polypeptides of the general structural formula (I)
  • X is any of the 20 naturally occurring amino acids (Phe, Leu, Ser, Tyr, Cys, Trp, Pro, His, GIn, Arg, Ne Met, Thr, Asn, Lys, VaI, Ala, Asp, Glu, Gly) and the indices standing at X represent the number of amino acids, the indices n and m being numbers between 0 and 500, preferably between 15 and 300, p being a number between 1 and 250, preferably 1-100, and C is cysteine, alanine, serine, glycine, methionine or threonine, with at least four of the radicals named C being cysteine, with the proviso that at least one of the peptide sequences abbreviated by X n or X m or X p represents at least 20 Amino acids long peptide sequence is that is not naturally associated with a hydrophobin, which cause a contact angle change of at least 20 ° after coating a glass surface.
  • the amino acids designated C 1 to C 8 are preferably cysteines; but they can also be replaced by other amino acids of similar space filling, preferably by alanine, serine, threonine, methionine or glycine. However, at least four, preferably at least 5, more preferably at least 6 and in particular at least 7, of the positions C 1 to C 8 should consist of cysteines. Cysteines can either be reduced in the proteins according to the invention or form disulfide bridges with one another. Particularly preferred is the intramolecular formation of CC bridges, in particular those with at least one, preferably 2, more preferably 3 and most preferably 4 intramolecular disulfide bridges. In the exchange of cysteines described above by amino acids of similar space filling, it is advantageous to exchange in pairs those C positions which are capable of forming intramolecular disulfide bridges with one another.
  • cysteines, serines, alanines, glycines, methionines or threonines are also used in the positions indicated by X, the numbering of the individual C-positions in the general formulas may change accordingly.
  • polypeptides are those of the general formula (II)
  • X is any of the 20 naturally occurring amino acids (Phe, Leu, Ser, Tyr, Cys, Trp, Pro, His, GIn, Arg, Ne Met, Thr, Asn, Lys, VaI, Ala, Asp, Glu, Gly) and the indices standing at X represent the number of amino acids, the indices n and m being numbers between 2 and 300 and C being cysteine, alanine, serine, glycine, methionine or threonine, at least four of the radicals designated C.
  • X n or X m represents a peptide sequence which is at least 35 amino acids in length, which is naturally not linked to a hydrophobin which after coating a glass surface has a contact angle change of at least 20 ° cause.
  • hydrophobins may have been isolated from microorganisms such as bacteria, yeasts and fungi.
  • hydrophobins which have been obtained by means of genetically modified organisms are suitable according to the invention.
  • proteins can be isolated more easily.
  • the isolation from a production cell is usually one of the first steps in the purification of a protein, provided the protein is produced and stored intracellularly.
  • a production cell is any type of cell or cell structure; in particular those cells of animal, plant or fungal origin or microorganisms from the group of Bacteria or Archaea.
  • Preferred production cells are recombinant organisms.
  • Particularly suitable production cells are prokaryotes (including archaea) or eukaryotes, especially bacteria including halobacteria and methanococci, fungi, insect cells, plant cells and mammalian cells, more preferably Escherichia coli, Bacillus subtilis, Bacillus.
  • the production cell can be used in the process of the invention immediately after culturing (e.g., fermentation); but it is also possible to kill the production cell first, for example by sterilization, and if necessary to enrich the cell mass by filtration of the culture medium.
  • the homogenizer for cell disruption consists either of a diaphragm with at least one inlet nozzle and a diaphragm with at least one outlet nozzle, wherein the nozzles are arranged axially to one another.
  • a static mixer In the space between the panels is a static mixer.
  • the diaphragms which can be used according to the method of the invention have at least one opening, ie at least one nozzle.
  • the two panels may each have any number of openings, but preferably not more than each 5 openings, more preferably not more than three openings, more preferably not more than two openings and more preferably not more than one opening.
  • Both diaphragms can have a different or the same number of openings, preferably both diaphragms have the same number of openings.
  • the apertures are perforated plates with at least one opening each.
  • the second diaphragm is replaced by a sieve, ie the second diaphragm has a multiplicity of openings or nozzles.
  • the sieves which can be used can span a large range of pore sizes, as a rule the pore sizes are between 0.1 and 250 ⁇ m, preferably between 0.2 and 200 ⁇ m, particularly preferably between 0.3 and 150 ⁇ m and in particular between 0, 5 and 100 microns.
  • the openings or nozzles can have any conceivable geometric shape; they can, for example, be circular, oval, angular with any number of corners, which if appropriate can also be rounded, or else star-shaped. Preferably, the openings have a circular shape.
  • the apertures are typically 0.05 mm to 1 cm in diameter, preferably from 0.08 mm to 0.8 mm, more preferably from 0.1 to 0.5 mm and in particular from 0.2 to 0 , 4 mm.
  • the two panels are preferably constructed so that the openings or nozzles are arranged axially to each other.
  • axial arrangement is to be understood that the flow direction generated by the geometry of the nozzle opening is identical for both diaphragms.
  • the opening directions of the inlet and outlet nozzles do not have to lie on a line, they can also be moved in parallel, as can be seen from the above statements.
  • the panels are aligned in parallel.
  • the thickness of the panels can be arbitrary.
  • the apertures preferably have a thickness in the range from 0.1 to 100 mm, preferably from 0.5 to 30 mm and particularly preferably from 1 to 10 mm.
  • the thickness (I) of the diaphragms is selected such that the quotient of diameter (d) of the openings and thickness (I) is in the range of 1: 1, preferably 1: 1, 5 and particularly preferably 1: 2.
  • the gap between the two panels can be of any desired length, as a rule the length of the intermediate space is 1 to 500 mm, preferably 10 to 300 mm and particularly preferably 20 to 100 mm.
  • a static mixer according to the invention, which can fill the route between the two panels completely or partially.
  • the static mixer extends over the entire length of the gap between the two panels.
  • Static mixers are known in the art. It may be, for example, a valve mixer or a static mixer with holes, one of corrugated fins or intermeshing webs. Furthermore, it may be a static mixer in helical form or in N-shape or such with heatable or coolable mixing elements.
  • a mechanical energy input can still take place in the intermediate space between the two diaphragms.
  • the energy can be introduced, for example, in the form of mechanical vibrations, ultrasound or rotational energy. This creates a turbulent flow that causes the particles in the gap to not agglomerate.
  • the mixing device may consist of a diaphragm with at least one inlet nozzle and a baffle plate, wherein, if appropriate, there is a static mixer in the intermediate space between the diaphragm and the baffle plate.
  • a mechanical energy input can take place in the intermediate space.
  • the second panel is replaced by a baffle plate.
  • the baffle plate usually has a diameter which is 0.5 to 20%, preferably 1 to 10% smaller than the pipe diameter at the point at which the baffle plate is installed.
  • the baffle plate can have any geometric shape, preferably in the form of a round disc, so that an annular gap can be seen in frontal supervision. It is also conceivable, for example, the shape of a slot or a channel.
  • the baffle plate can be mounted at different distances to the first panel analogous to the second panel in the variant described above. As a result, the gap between the diaphragm and the baffle plate is arbitrarily long, as a rule, the length of the intermediate space is 1 to 500 mm, preferably 10 to 300 mm and particularly preferably 20 to 100 mm.
  • the process according to the invention has several advantages over the processes known from the prior art, since particularly high yields of the protein in active form are obtained.
  • the temperature at which the biological cell disruption is carried out by the inventive method is usually 0 to 150 0 C, preferably, 5 to 80 0 C, particularly preferably 20 to 40 0 C.
  • all of homogenizing units used in the device can be temperature ,
  • Homogenization is typically carried out at pressures above atmospheric pressure, i. > 1 bar performed. However, the pressures do not exceed a value of 10,000 bar, so that preferably homogenization pressures of> 1 bar to 10,000 bar, preferably 5 to 2,000 bar and particularly preferably from 10 to 1500 bar are set.
  • the production cell concentrations used in the process according to the invention are about from 3 to 25% by weight, preferably from 5 to 15% by weight.
  • the protein isolates obtained by the method according to the invention can be used either directly or after renaturation of the protein, further purification and, if appropriate, formulation.
  • a further subject of the invention is therefore a production process for a protein, which inter alia comprises the above-described isolation from a production cell.
  • Purification of the proteins can be achieved by known processes after the process according to the invention.
  • the purification is particularly successful when the cell protein in sg. Inclusion Bodies is present. In this case, they can be separated particularly advantageously by centrifugal separation in a separator or nozzle separator selectively from the unwanted cell debris.
  • the further purification with known, chroma ⁇
  • ll g. such as molecular sieve chromatography (gel filtration), such as Q-sepharose chromatography, ion exchange chromatography and hydrophobic chromatography, as well as other conventional techniques, such as centrifugal separation, ultrafiltration, crystallization, salting out, dialysis, and native gel electrophoresis.
  • molecular sieve chromatography gel filtration
  • Q-sepharose chromatography Q-sepharose chromatography
  • ion exchange chromatography ion exchange chromatography
  • hydrophobic chromatography hydrophobic chromatography
  • chromatographic techniques such as Q-sepharose chromatography, ion exchange chromatography and hydrophobic chromatography, as well as other conventional techniques such as centrifugal separation, ultrafiltration, crystallization, salting out, dialysis and native gel electrophoresis .
  • chromatographic techniques such as Q-sepharose chromatography, ion exchange chromatography and hydrophobic chromatography, as well as other conventional techniques such as centrifugal separation, ultrafiltration, crystallization, salting out, dialysis and native gel electrophoresis .
  • the FER mentation is stopped by cooling to 4 0 C.
  • the cell mass is run at a flow rate of 200 l / h over a plate separator. From 3300 kg of fermentation broth, 860 kg of concentrate are obtained.
  • the dry matter content (TS) of the resuspended cell broth is 5% by weight.
  • the suspended cells are brought to the desired operating pressure by means of a high-pressure pump (Fig. 1). The subsequent pressure release takes place in the described high-pressure aperture. The cell disruption takes place. Responsible are shear, strain and turbulent flow forces that attack the suspended microorganisms.
  • Fig.2 Flow diagram of the high-pressure diaphragm.
  • 4 more 1000 mL Erlenmeyer flasks with baffles (each with 200 mL complex medium) are inoculated with 1 mL each of the first preculture and incubated at 37 ° C.
  • Example 1-8 The scale-up from the laboratory (Examples 1-8) to the pilot plant scale was carried out at throughputs of up to 700 l / h and pressures up to 2500 bar. For the temperatures on the input side, the same conditions apply as in Example 1-8 (see above).
  • the cell-containing suspension is passed through a 70 ⁇ m pre-filter by means of a compressed air membrane pump. With a pre-pressure of at least 1.5 bar, the cell-containing suspension is brought to the appropriate pressure with a high-pressure piston pump and then passes through the so-called diaphragm block.
  • the aperture block consists of 2 panels.
  • the first panel has 14 holes each with a diameter of 0.1 or 0.2 mm (see above). After passing through a hole with 8 mm diameter, the cell-containing suspension passes the second aperture with a diameter of 1, 5 mm to the non-pressure side. Subsequently, the cell-containing suspension passes through the radiator.
  • Total dry substance Dried sample, contains total dry matter. Dry biomass: 2 times washed and subsequently dried sample
  • the degree of digestion [A) is defined via
  • the coating properties of the redissolved spray-dried or spray-granulated hydrophobininfusion protein are used.
  • the evaluation of coating properties is preferred Glass or Teflon made as models for hydrophilic or hydrophobic surfaces.
  • the samples are air dried and the contact angle (in degrees) of a drop of 5 ⁇ l of water is determined. There are e.g. the following values:
  • YaaD-DewA fusion protein (control: no protein, YaaD-DewA-His 6 : 100 mg / L purified fusion partner):
  • a portion of the resuspended cells are digested using a Microfluidizer processor M-7125-30 S.N. 200414 with the "Ceramic IXC H10Z-6 slot" and "Ceramic APMH30Z” digestion chambers from Microfluidics at a differential pressure of 1750 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • Example 2 A part of the resuspended cells is disrupted via the high-pressure diaphragm (high-pressure diaphragm) at a differential pressure of 500 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 1000 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 1200 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 1400 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 1800 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 2000 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • a part of the resuspended cells is digested via the high-pressure diaphragm (HD diaphragm) at a differential pressure of 2400 bar.
  • the flow rate is 3.3 L / min.
  • the live cell count resulting from cell disruption after a single run is listed in Tab.
  • the cell suspension is determined using the high pressure orifice at a differential pressure of 1000; 1500 and 2000 bar unlocked at a flow rate of 700 l / h and the respective armordzelliere determined (see Table 2).
  • the cell broth which has been digested at 2000 bar differential pressure, is passed through a nozzle separator at a flow rate of 400 l / h.
  • the washing step is repeated. This results in an IB discharge of 370 kg with 7.9% by weight of dry matter content.
  • This concentrate is adjusted to pH 12.5 and after 15 min. the pH is lowered to 9.
  • the neutralized hydrophobin-containing solution is driven through a tube centrifuge to separate solids. According to SDS-PAGE analysis, the hydrophobin is contained in the supernatant after the final centrifugation.
  • aqueous hydrophobin solution This supernatant is referred to below as "aqueous hydrophobin solution.”
  • the dry matter content of the aqueous hydrophobin solution is 3.4% by weight.
  • This solution is sprayed with a two-fluid nozzle type Gerig Gr.O with an injection rate of 41 kg / h in 1200 kg / h of nitrogen in cocurrent.
  • the spray tower has a diameter of 800 mm and a height of 12 m.
  • the inlet temperature of the drying gas is 161 °.
  • the outlet temperature of the drying gas is 80 °.
  • the deposition takes place in the filter, in which 31, 7 kg of dry material are recovered. From the tower 6.1 kg dry matter swept.
  • the contact angles of the redissolved hydrophobin-containing dry material resulting from the activity test are listed in Tab.
  • the protein gel of the redissolved dry matter is
  • Tab. 1 Hordzelliere and degree of digestion for the blank sample and Examples 1-8.
  • Fig. 1 Living cell count [1 / mL] of Examples 1-8.
  • Fig. 2 degree of digestion [-] of Examples 1-8.
  • Fig. 3 Protein gel Example 9:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un procédé destiné à dissoudre des cellules biologiques au moyen d'un dispositif d'homogénéisation, comprenant: a) un écran présentant au moins une buse d'entrée et un écran présentant au moins une buse de sortie. Un mélangeur statique est placé dans l'espace situé entre les écrans, et de l'énergie mécanique supplémentaire peut être éventuellement introduite. Ledit dispositif peut comprendre b) un écran présentant au moins une buse d'entrée et une plaque de déviation. Eventuellement, un mélangeur statique est ajouté dans l'espace situé entre l'écran et la plaque d'impact et/ou de l'énergie mécanique peut être également introduite.
EP07788230A 2006-08-15 2007-08-06 Procédé permettant d'isoler des protéines des cellules de production Withdrawn EP2054498A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07788230A EP2054498A1 (fr) 2006-08-15 2007-08-06 Procédé permettant d'isoler des protéines des cellules de production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06118941 2006-08-15
PCT/EP2007/058102 WO2008019964A1 (fr) 2006-08-15 2007-08-06 Procédé permettant d'isoler des protéines des cellules de production
EP07788230A EP2054498A1 (fr) 2006-08-15 2007-08-06 Procédé permettant d'isoler des protéines des cellules de production

Publications (1)

Publication Number Publication Date
EP2054498A1 true EP2054498A1 (fr) 2009-05-06

Family

ID=38613240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07788230A Withdrawn EP2054498A1 (fr) 2006-08-15 2007-08-06 Procédé permettant d'isoler des protéines des cellules de production

Country Status (5)

Country Link
US (1) US20090233348A1 (fr)
EP (1) EP2054498A1 (fr)
JP (1) JP2010500042A (fr)
CN (1) CN101522884B (fr)
WO (1) WO2008019964A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859106B2 (en) 2005-03-31 2014-10-14 Basf Se Use of polypeptides in the form of adhesive agents
EP2042155A1 (fr) * 2007-09-28 2009-04-01 Basf Se Procédé de suppression de substances indissolubles dans l'eau de surfaces de substrat
US20130040340A1 (en) 2011-02-07 2013-02-14 E. I. Du Pont De Nemours And Company Production of alcohol esters in situ using alcohols and fatty acids produced by microorganisms
EP2687592A1 (fr) * 2012-07-20 2014-01-22 greenovation Biotech GmbH Filtration de surnageants de cultures cellulaires
UA119797C2 (uk) 2014-11-05 2019-08-12 Басф Се Спосіб одержання агрохімічної композиції зі зниженою токсичністю шляхом подрібнювання попередньо приготовленої суміші пестициду й гідрофобіну
DE102016202139A1 (de) * 2016-02-12 2017-08-17 Hamilton Bonaduz Ag Zellvereinzelungsvorrichtung und Verwendung einer Strömungsformation zur Zellvereinzelungsvorrichtung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH069502B2 (ja) * 1986-06-04 1994-02-09 三菱重工業株式会社 菌体の粉砕方法
EP0374817A3 (fr) * 1988-12-21 1990-09-26 Takeda Chemical Industries, Ltd. Méthode pour rompre les particules de virus
US5837529A (en) * 1994-10-17 1998-11-17 Genzyme Corporation Method for lysing cells
US6455287B1 (en) * 1995-02-23 2002-09-24 Wyeth Mechanical disruption of bacterial cells for plasmid recovery
US6150507A (en) * 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
JPH0910622A (ja) * 1995-06-27 1997-01-14 Asupuro Kk クロレラ細胞壁の破砕方法および破砕装置
TW426733B (en) * 1995-10-06 2001-03-21 Merck & Co Inc Method of disrupting cultured cells using an impinging jet device
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
JPH1142440A (ja) * 1997-07-28 1999-02-16 Jiinasu:Kk クロレラの破砕方法およびクロレラ破砕物並びにその安定化方法、および安定化されたクロレラ破砕物
DE19749735C1 (de) * 1997-11-11 2000-02-10 Invent Gmbh Entwicklung Neuer Technologien Verfahren und Vorrichtung zur Herstellung von Enzymen
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
JP2000287671A (ja) * 1999-04-02 2000-10-17 Japan Steel Works Ltd:The 単細胞破砕方法
US6942169B2 (en) * 2001-06-06 2005-09-13 Integrated Sensing Systems Micromachined lysing device and method for performing cell lysis
EP1664277B1 (fr) * 2003-09-17 2011-11-09 Aventis Pharma S.A. Procede de preparation d'adn plasmide de qualite pharmaceutique
JP4592474B2 (ja) * 2004-07-13 2010-12-01 成雄 安藤 高圧均質化装置、および高圧均質化方法
CA2596661C (fr) * 2005-02-07 2013-12-10 Basf Aktiengesellschaft Nouvelles proteines de fusion d'hydrophobine, leur production et leur utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008019964A1 *

Also Published As

Publication number Publication date
WO2008019964A1 (fr) 2008-02-21
US20090233348A1 (en) 2009-09-17
JP2010500042A (ja) 2010-01-07
CN101522884B (zh) 2013-08-21
CN101522884A (zh) 2009-09-02

Similar Documents

Publication Publication Date Title
WO2008019964A1 (fr) Procédé permettant d'isoler des protéines des cellules de production
EP1848733B1 (fr) Nouvelles proteines de fusion d'hydrophobine, leur production et leur utilisation
AT501898B1 (de) Verfahren zur herstellung von getrockneten mikroorganismen
Bénard-Gellon et al. Toxicity of extracellular proteins from Diplodia seriata and Neofusicoccum parvum involved in grapevine Botryosphaeria dieback
DE60025733T2 (de) Verfahren zur verminderung der schaumbildung während der kultivierung eines mikroorganismus
EP1848734A2 (fr) Procede pour enduire des surfaces avec des hydrophobines
Izgu et al. Inhibition of Penicillium digitatum and Penicillium italicum in vitro and in planta with Panomycocin, a novel exo-β-1, 3-glucanase isolated from Pichia anomala NCYC 434
EP0507968A1 (fr) Procédé de production par fermentation et isolement de cyclosporine A ainsi que de nouvelles souches productrices de cyclosporine
EP2054687B1 (fr) Procédé de fabrication de préparations d'hydrophobine s'écoulant librement, sèches
DE4109457A1 (de) Verfahren zur extrazellulaeren herstellung von hochmolekularen homopolyscchariden und zu ihrer anwendung, sowie die entsprechenden pilzstaemme
DE2457090A1 (de) Vakzin und verfahren zu dessen herstellung
CN102838655A (zh) 一种毕赤酵母发酵液的固液分离方法
DE4203315A1 (de) Verfahren zur gewinnung von pankreatin
DE102010062600A1 (de) Hydrophobisiertes Proteinhydrolysat
DE19641213B4 (de) Cyclische Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1088076A1 (fr) PROCEDE DE PRODUCTION DE HbSAg RECOMBINE
EP2029759B1 (fr) Procédé de séparation de particules de polyhydroxyalcanoates obtenues par fermentation en utilisant un séparateur à buses
DE102009032645B3 (de) Mikroröhren, umfassend Bestandteile der äußeren Membran von E. coli Zellen und rekombinant exprimierte S-Layer-Proteine, Verfahren zu ihrer Herstellung und Verwendung
Böker Biopolymere–Funktionsträger in der Materialforschung: Polymere Materialien mit biologischen Funktionen und Biomaterialien für die Medizin
DE60104127T2 (de) Verfahren zur abtrennung von weizenmehl unter verwendung eines transglutaminase-enzyms
WO2023006995A1 (fr) Biosynthèse de collinolactone et préparation
EP0621897B1 (fr) Procede de fabrication d'enzymes lignolytiques au moyen de champignons de pourriture blanche
DE102023115905A1 (de) Regelbarer Aufschluss von eukaryotischen Protoplasten zur Freisetzung intakter Zellorganellen
DE102004040014B4 (de) Aureonitrile, Verfahren zu ihrer Herstellung und ihre Verwendung
Mohamed et al. Endophytic Synthesis Of Silver And Silver Chloride Nanoparticles From Talaromyces Stipitatus Of Capsicum Annuum L.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090316

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17Q First examination report despatched

Effective date: 20090609

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170301